Skip to main content
Caplight Logo









Foray Bioscience

Foray Bioscience

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://foraybio.com/

Last Round

Seed

Jun 25, 2024

Total Funding Raised

$3.88M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Foray Bioscience is a biotechnology company that develops plant cell culture and biomanufacturing technologies to produce harvest-free plant-based materials, molecules, and seeds.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Vertical SaaS, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS, Government Contracts

AI Layer

Application

Keywords

plant cell culturebiomanufacturingin vitro plant culturelab-grown plantsplant biotechnologyR&D workspacevertical SaaSpredictive biomanufacturingcell-cultured seedssynthetic biologyprotocol managementagtechexperimental design toolssustainable materialsbio-foundry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Foray Bioscience Comparables

Compare Foray Bioscience with similar companies based on industry and business-model similarity.

Foray Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ayana Bio
66%
Benchling
62%
DFB Pharmaceuticals
60%

Foray Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 25, 2024
Pre SeedJul 1, 2023

Key People

Founding team and executive leadership

Ashley Beckwith

Founder and CEO

Founding Team

Foray Bioscience Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 419% MoM, reaching 4.4K.

  • Jul 17, 2026

    Grew 18% QoQ, from 17 to 20 employees.

Foray Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Foray Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Foray Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range18
Year Founded2022
Last FundingJun 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?